Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Program data pending ClinicalTrials.gov matching
· Last scored 2026-03-15
73.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
Quick Facts: Pharmaron Biologics
- Signal Score
- 73.0/100 (as of 2026-03-15)
- Quality Compliance
- Assessment pending
- Headquarters
- San Diego, CA · Shaoxing, CN
- Modalities
- AAV, Lentiviral, Plasmid
- Active CGT Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CGT manufacturing intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
83.0
Publicly traded — financial transparency
Source: SEC EDGAR, press monitoring
Subsidiary of Pharmaron
SEC FilingsParent: Pharmaron
Publicly traded — financial transparency
Capacity
63.0
2 CGT manufacturing sites
Sites: San Diego, CA, Shaoxing, China
Source: SEC EDGAR, press monitoring, company profiles
2 CGT manufacturing sites
2 CGT manufacturing sites
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: